300+ investors in your industry, stage, and region Get
Any industry
Energy
Proptech
Community
Health Care
Gaming
Artificial Intelligence
Climate
Biotech
Impact
Google
EdTech
Sustainability
Clean Energy
Retail
Finance
Digital Media
Local
Enterprise Software
Email
Travel
Recruiting
Platforms
Fitness
Social
Wine and Spirits
CleanTech
Mobile Apps
InsurTech
Oil and Gas
Theatre
Non Profit
Social Impact
Celebrity
Cryptocurrency
SaaS
Film
Crowdfunding
Venture Capital
Infrastructure
Restaurants
Sporting Goods
Fashion
LGBT
Photography
Renewable Energy
Organic Food
Machine Learning
Agriculture (AgTech)
Media (Entertainment)
Facebook
Blockchain
Beauty
Real Estate
Life Science
B2B
Publishing
Food and Beverage
Social Network
Web3
Video Games
Big Data
Education
Medical Device
Medical
Wellness
Payments
Art
Social Media
Music
Franchise
Android
Mobile
Internet
Legal
Construction
eSports
Manufacturing
Sports
Automotive
Hospitality
Financial Services
Mobile Advertising
Cannabis
Biotechnology
FinTech
Consumer
Marketplace
Hardware
Transportation
Enterprise
Software
Any country
Australia
South Korea
Europe
Brazil
Indonesia
Singapore
Saudi Arabia
Africa
Oceania
LATAM
Asia
Middle East
Costa Rica
Gibraltar
Bahrain
Greece
Finland
Algeria
Liberia
Mexico
Lebanon
Norway
Mauritius
Italy
Israel
Taiwan
Tunisia
Zambia
Russian Federation
Nigeria
Jamaica
Honduras
Tajikistan
Sweden
Isle of Man
Mozambique
Luxembourg
Albania
Pakistan
Zimbabwe
Togo
Puerto Rico
Romania
Bangladesh
San Marino
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cameroon
Oman
Colombia
Guatemala
Seychelles
Ireland
China
Japan
Qatar
South Africa
Spain
Sri Lanka
Armenia
Azerbaijan
Austria
Barbados
Argentina
Vietnam
United Arab Emirates
Bulgaria
Belarus
Estonia
Belgium
Bermuda
Bolivia
Egypt
France
Bahamas
Czech Republic
Chile
Denmark
Faroe Islands
Georgia
Ecuador
Belize
Croatia
Dominican Republic
Hong Kong
Switzerland
Ethiopia
Grenada
Ghana
Iraq
Hungary
Iceland
Jersey
Jordan
Kuwait
Liechtenstein
Lithuania
Morocco
Latvia
Mali
Marshall Islands
Myanmar
Malta
Malaysia
Nicaragua
Namibia
Peru
Philippines
Poland
Panama
Portugal
Rwanda
Sierra Leone
Serbia
Slovenia
Senegal
El Salvador
Thailand
Tanzania
Uruguay
Turkey
Ukraine
Uganda
Uzbekistan
Venezuela
New Zealand
Cyprus
United States
India
Germany
Canada
United Kingdom
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 25 Biotech VC Funds & Investors in Taiwan (June 2026)

The most active venture capital funds investing in Taiwan Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Taiwan Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Darwin Venture Management
VC Fund
4 Taiwan, United States, Japan Seed, Series A Software, Manufacturing, Information Technology $350k–$76M
WI Harper Group
VC Fund
3 United States, Taiwan, China Series A, Seed, Series B Software, Health Care, Biotechnology $1.1M–$41M
Translink Capital
VC Fund
3 United States, China, South Korea Series A, Series B, Series C Software, Information Technology, Artificial Intelligence $4M–$55M
National Development Fund of Taiwan Government
VC Fund
2 Taiwan, United States, China Seed, Series A, Series B Software, Information Technology, Health Care $400k–$30M
AVA Angels
VC Fund
2 Taiwan, United States, Hong Kong Seed, Series A, Pre-Seed Software, E-Commerce, Information Technology $330k–$10M
NCTU Angel Club
VC Fund
2 Taiwan, United States Seed, Series A Medical, Health Care, Biotechnology $750k–$5M
Maxpro Ventures
VC Fund
2 Taiwan Series A, Venture - Series Unknown Biotechnology, Retail, Medical
Verge HealthTech Fund
VC Fund
2 Estonia, Singapore, United Kingdom Seed, Pre-Seed, Series A Health Care, Medical Device, Medical $500k–$4.6M
China Development Industrial Bank (CDIB)
VC Fund
2 United States, Taiwan, China Series B, Series A Biotechnology, Health Care, Medical $2.8M–$51M
Fubon Financial Holdings
VC Fund
2 Taiwan, United States, Israel Series A, Series B Biotechnology, Software, Medical $5M–$27M
BE Healthcare Ventures
VC Fund
1 Taiwan, Thailand Seed, Series A, Series B Health Care, Medical, Software
VENTURE+
VC Fund
1 Taiwan Series A, Seed SaaS, Software, Rental
Alzheimer's Drug Discovery Foundation
VC Fund
1 United States, Canada, Spain Grant, Series A Biotechnology, Health Care, Health Diagnostics
Taiwania Capital Management Corporation
VC Fund
1 United States, Taiwan, United Kingdom Series A, Series B, Seed Software, Artificial Intelligence, Biotechnology $3M–$85M
TMI Holding Corp.
VC Fund
1 Taiwan, United States Series D Life Science, Consumer, Software
Alibaba Entrepreneurs Fund
VC Fund
1 Hong Kong, Taiwan, United States Series A, Seed, Series B Software, E-Commerce, Artificial Intelligence $510k–$150M
TaiAn Technologies
VC Fund
1 Taiwan, United States Series A, Series B Biotechnology, Medical, Therapeutics $13M–$23M
CDIB Capital
VC Fund
1 China, Taiwan, United States Series B, Series A, Series C Health Care, Biotechnology, Information Technology $1.5M–$100M
DCI Partners
VC Fund
1 Japan, Taiwan, United States Series B, Series A Biotechnology, Health Care, Product Research $7.1M–$553M
Mega International Commercial Bank
VC Fund
1 Taiwan, Philippines Series A, Debt Financing Banking, Payments, Biotechnology $158M–$500M
Pangu Venture Capital
VC Fund
1 China, Taiwan, United States Series A, Seed, Angel Biotechnology, Apps, SaaS $12M–$27M
Lippo Group
VC Fund
1 United States, Singapore, China Seed, Series A Internet, E-Commerce, FinTech $3.5M–$4.8M
Taiwan Surface Mounting Technology
VC Fund
1 Taiwan Seed Medical, Health Care, Biotechnology
Might Electronic
VC Fund
1 Taiwan Seed Medical, Health Care, Biotechnology
Integrated Capital
VC Fund
1 India, Taiwan, Croatia Series A, Seed, Series B E-Commerce, Food and Beverage, Automotive $3.4M–$40M
Access all 25 VC funds in Taiwan Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Darwin Venture Management
VC Fund · Taipei, T'ai-pei, Taiwan · 4 investments in Taiwan Biotech startups

Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Seed, Series A
  • Geography: Taiwan, United States, Japan

Investor stats

  • Total investments: 124
  • Round size: Seed $350k–$43M; Series A $3M–$76M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • BitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
  • Instalimb — Instalimb is the world's first 3D printing prosthesis business.
  • Findy — Findy is a Japanese company once surprised the world by sending out products such as cars and home appliances one after another
Show all investments...

WI Harper Group
VC Fund · San Francisco, California, United States · 3 investments in Taiwan Biotech startups

We take a diversified approach, investing in the early stage, across multiple sectors with our deep domain expertise.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: United States, Taiwan, China

Investor stats

  • Total investments: 148
  • Round size: Seed $1.1M–$5M; Series A $2M–$15M; Series B $6M–$41M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $174M in 2016

Portfolio highlights

  • DivX — Download free DivX Software to play, convert and cast video including DivX, AVI, MKV and HEVC files up to 4K. Play AVI and convert to MP4!
  • Ultriva — Ultriva is a lean manufacturing software that enables you to adapt quickly and deliver impressive results. Experience modern lean manufacturing now. Learn more.
  • Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
Show all investments...

National Development Fund of Taiwan Government
VC Fund · Taipei, T'ai-pei, Taiwan · 2 investments in Taiwan Biotech startups

The national development fund is the management unit of the non-business cycle budget fund, which is tasked with grouping. It aims to accelerate the industrial innovation value-added, promote economic transformation and national development, and help china's industrial innovation value-added, research and development and self-owned brands. Thefinancing method or assisting the competent authorities of the central government to handle the relevant plans to complete the purposes specified in article 30 of the "industry innovation ordinance".

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Taiwan, United States, China

Investor stats

  • Total investments: 40
  • Round size: Seed $400k–$7M; Series A $2M–$15M; Series B $10M–$30M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • MedicalTek — MedicalTek (MDTK) is located in Taichung, Taiwan. We specialize in developing and manufacturing in MonoStereo 3D endoscopic imaging system that using in MIS surgery.
  • H2U — Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products.
  • Numbers Protocol — Explore Numbers Protocol, a leader in blockchain-driven digital media authenticity aligned with C2PA standards. Join our robust platform to secure and verify digital content through advanced blockchain technology.
Show all investments...

AVA Angels
VC Fund · Taipei, T'ai-pei, Taiwan · 2 investments in Taiwan Biotech startups

AVA Angels is an angel group which focus on connecting angel stage to venture stage of startups. AVA Angels has brought together many outstanding angel investors to find and evaluate together high-quality investment targets, to quickly establish the startup ecosystem and the startup investors network.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Taiwan, United States, Hong Kong

Investor stats

  • Total investments: 39
  • Round size: Seed $330k–$5M; Pre-Seed $350k–$2.5M; Series A $3.9M–$10M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Zeabur — A platform that help you deploy your service with one click, No matter what programming language you use, what framework you use.
  • Pet 100% — Pet 100% is a pet store that offers grooming services, nutritional supplements, deworming for pets, and protective services for animals.
  • AlleyPin — AlleyPin Interactive helps SMBs grow their businesses by elevating their online presence and bringing more customers to their doorsteps. These great results are achieved through our proprietary marketing solutions making it easy for customers of the SMBs to leave great online reviews.
Show all investments...

NCTU Angel Club
VC Fund · Taipei, T'ai-pei, Taiwan · 2 investments in Taiwan Biotech startups

NCTU Angel Club is an angel investment group that encourages an aspiring young person to start a business.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: Taiwan, United States

Investor stats

  • Total investments: 5
  • Round size: Seed $2.4M–$3M; Series A $750k–$5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MoBagel — MoBagel’s vision is to bring AI-driven decision making to enterprises through software and services. MoBagel has empowered global enterprises to extract business insights and create value from their data across industries including retail, telecom, manufacturing, banking, and more.
  • Hukui Bio — Founded in November 2013, HuKui Bio provides total solution and value-added services to global medical devices customers. By focusing on medical electronics and handheld devices for digital healthcare and telemedicine, we do the designing and development in Taiwan, manufacturing in Asia, and delivering our sales & services globally. Combiningseasoned experts and investors from biomedical, tech, and financial industries, we strive to be the best partner in the Asia-Pacific region for MedTech developers, startups and corporates by completing projects on-time, on-budget and by meeting global quality standards concurrently. Our US company, HuKui Tech, is a subsidiary based in the Bay area, 100% owned by HuKui Bio since 2020.
  • Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
Show all investments...

Maxpro Ventures
VC Fund · Taipei, T'ai-pei, Taiwan · 2 investments in Taiwan Biotech startups

Maxpro Ventures is an investment firm focused on breakthrough biomedical technology companies. We identify and invest in such excellent companies worldwide with our private equity and venture capital expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Retail, Medical
  • Stage:Series A, Venture - Series Unknown
  • Geography: Taiwan

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
  • StellarCell.Bio — StellarCell.Bio is a regenerative medicine company focused on the research, development, and implementation of cell therapy technologies.
  • Full Chain Materials International — Full Chain Materials is a Retail company focused on supplying and sourcing a broad range of chemicals and equipment to customers.
Show all investments...

Verge HealthTech Fund
VC Fund · Singapore, Central Region, Singapore · 2 investments in Taiwan Biotech startups

We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging Asia​We believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Estonia, Singapore, United Kingdom

Investor stats

  • Total investments: 24
  • Round size: Seed $500k–$4.6M; Pre-Seed $500k–$1M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $17k in 2021

Portfolio highlights

  • Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
  • Lifeyear — Digital-first heart care. At scale.
  • CareLoop Health — CareLoop, an innovation emerging from the University of Manchester, furnishes patients with digital support resources while simultaneously providing healthcare professionals with the means to monitor and track patient symptoms.
Show all investments...

China Development Industrial Bank (CDIB)
VC Fund · Taipei, T'ai-pei, Taiwan · 2 investments in Taiwan Biotech startups

CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan's industrial development, CDIB has built up a wealth of experience in high-tech investment while its investment overseas has extended to the US,Japan, Korea and S.E. Asia.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Taiwan, China

Investor stats

  • Total investments: 62
  • Round size: Series A $2.8M–$34M; Series B $20M–$51M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Eden Biologics — Eden Biologics, formerly known as JHL Biotech ("JHL") , is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development tocommercial manufacturing with both global and regional regulatory affairs expertise.
  • AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
  • Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
Show all investments...

Fubon Financial Holdings
VC Fund · Taipei, T'ai-pei, Taiwan · 2 investments in Taiwan Biotech startups

Fubon Financial Holdings has built a strong lineup of financial service companies. Its major subsidiaries include Fubon Life, Taipei Fubon Bank, Fubon Bank (Hong Kong), Fubon Bank (China), Fubon Insurance, Fubon Securities, and Fubon Asset Management. Fubon Financial Holdings had total assets of US$283.9 billion as of the end of 2019, rankingsecond among Taiwan’s financial holding companies, and it has been the most profitable company in the industry in terms of earnings per share (EPS) for eleven consecutive years. The company was also named to the Fortune Global 500 for the second consecutive year in 2019.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical
  • Stage:Series A, Series B
  • Geography: Taiwan, United States, Israel

Investor stats

  • Total investments: 11
  • Round size: Series A $5M–$27M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
  • AnnJi Pharmaceutical — AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). Thefocus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs.
  • Tetanti Agribiotech Inc. — Dr. Young holds a PhD degree in agronomy and soil science awarded by University of Hawaii. He is the pioneer in the field of organic fertilizer and soil microorganisms in Taiwan and was awarded the Academician honor in 2016.TTT® technology is the world’s only destructive and innovative concept that revolutionizes the traditional microbialcomposting process with the use of enzymes to stabilize and mature organic wastes. It raises the maturing efficiency more than 100-fold, and our zero pollution composting technology is able to avoid bad smell and waste water produced during the process.Dr. Young has profound influence on the industry in Taiwan and will lead our business to expand internationally as well as establish our group at the top of circular economy.•Broad microorganism and enzyme database:We possess more than 7,000 bacterial isolates that can provide functional and optimized enzyme formulations for different composting materials. •Professional know-how service:The rapid composting technology is a combination of microbiology, biochemistry, soil science, physics, as well as long term practical experiences. It can provide all-around total solution services for any organic wastes. •No more NIMBY protests:Rapid composting technology is pollution-free and can resolve the protests from the neighborhood.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
BE Healthcare Ventures
VC Fund · Taipei, T'ai-pei, Taiwan · 1 investments in Taiwan Biotech startups

BE Health Ventures is a boutique advisory and investment company, specializing in technologies, financials and healthcare industries.

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Series A, Series B
  • Geography: Taiwan, Thailand

Investor stats

  • Total investments: 7
  • Lead/follow: 57% lead, 43% follow

Portfolio highlights

  • AIM — AIM focuses on affordable and easy access to early preventive detection, precision diagnosis and automated prognosis monitoring of prevailing chronic diseases at vast installations of points-of-care.
  • Meticuly — Meticuly is a global leader in 3D printed patient specific implant. We use cutting-edge technology to create precise, customized implants for improved patient care. Visit to learn more!
  • H2U — Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products.
Show all investments...

VENTURE+
VC Fund · Taipei, T'ai-pei, Taiwan · 1 investments in Taiwan Biotech startups

VENTURE+ is the next generation venture capital bringing founders not only MONEY but also STRATEGIC VALUES. The company invests in early-stage companies and helps them with growth strategy and critical resources. With solid track records and hands-on experiences, VENTURE+ often plays a co-founding partner role providing more doing than talking. Weare thrilled and good at helping startups make an impact on the world.

Show more...

Investment focus

  • Industry: SaaS, Software, Rental
  • Stage:Series A, Seed
  • Geography: Taiwan

Investor stats

  • Total investments: 7
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • NUEIP — NUEIP focuses on creating smart databases, data visualization, and customized charts to enhance business operations efficiency.
  • 25sprout — 25sprout is a digital creative consultancy that provides website development, SaaS, business automation, software and app design.
  • Yifang Life — Yifang Life offers services related to rental renovations, leasing, and management, including a tenant management rental plan for tenants.
Show all investments...

Alzheimer's Drug Discovery Foundation
VC Fund · New York, New York, United States · 1 investments in Taiwan Biotech startups

The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease. Our pioneering biomedical venture philanthropy approach allows us to invest in the most promising drug discovery and development programs around the world in both academic institutions andbiopharmaceutical companies. Since our founding in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Health Diagnostics
  • Stage:Grant, Series A
  • Geography: United States, Canada, Spain

Investor stats

  • Total investments: 49
  • Lead/follow: no public data

Portfolio highlights

  • Modulo Bio — Modulo is decoding the neuroimmune system. Applying science and engineering to identify new treatment paths for neurodegenerative diseases.
  • Alamar Biosciences — Alamar Biosciences is a proteomics company redefining the limits of Protein Biomarker Detection with unrivaled precision. Learn more about what we offer here.
  • University of Gothenburg — University of Gothenburg is a school in Gothenburg.
Show all investments...

Taiwania Capital Management Corporation
VC Fund · Taipei, T'ai-pei, Taiwan · 1 investments in Taiwan Biotech startups

NEWS Nurturing Stalwarts of Future Industries Taiwan us [...]

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, Taiwan, United Kingdom

Investor stats

  • Total investments: 79
  • Round size: Seed $3M–$11M; Series A $4.9M–$85M; Series B $10M–$55M
  • Lead/follow: 57% lead, 43% follow

Portfolio highlights

  • Opsera — Opsera automates any CI/CD toolchain, enables declarative pipelines, and provides unified insights across your entire software delivery process.
  • Viracta Therapeutics — Our team possesses deep, cross-functional experience and shares a longstanding commitment to developing new medicines to benefit cancer patients. Management Strategic Advisor Board of Directors Scientific Advisory Board
  • Regenacy Pharmaceuticals — Regenacy Pharmaceuticals is a pioneer in developing novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme ("HDAC") inhibitors.
Show all investments...

TMI Holding Corp.
VC Fund · Taipei, T'ai-pei, Taiwan · 1 investments in Taiwan Biotech startups

TMI Holding Corp. is a Taipei-based, institutionalized angel investment firm that funds internet and mobile startups.

Show more...

Investment focus

  • Industry: Life Science, Consumer, Software
  • Stage:Series D
  • Geography: Taiwan, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • SmartAnalyst — Putnam is a trusted consulting partner that bridges the highest levels of scientific and strategic excellence for global life science companies.
  • R+W Studios — R+W is a global agency & startup incubator based in Hong Kong, Taipei, New York and Washington DC.
Show all investments...

Alibaba Entrepreneurs Fund
VC Fund · Causeway Bay, Hong Kong Island, Hong Kong · 1 investments in Taiwan Biotech startups

The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, Taiwan, United States

Investor stats

  • Total investments: 68
  • Round size: Seed $510k–$7M; Series A $2M–$68M; Series B $7M–$150M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — raised $130M in 2015

Portfolio highlights

  • PanopticAI — PanopticAI is a health system that uses artificial intelligence and signal processing to comprehend the human body and improve health.
  • Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
  • Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Show all investments...

TaiAn Technologies
VC Fund · Taipei, T'ai-pei, Taiwan · 1 investments in Taiwan Biotech startups

TaiAn Technologies Corporation is a technology advisory company that specializes in commercializing intellectual properties in the life sciences. Our team comprised of numerous biomedical experts that work closely with investment professionals to support up-and-coming life science technologies. Most importantly, we are entrusted by our shareholdersto explore technology platforms in the life sciences arena, to build upon the novel technologies, and to transform them into viable business opportunities supporting existing or creating new entities. Our shareholders comprised of Development Fund of the Executive Yuan of Taiwan as well as numerous conglomerates that are recognized in Taiwan and internationally well known. Leveraging our shareholders/ partners' resources and our strong management team, our multiplex services create synergies with Taiwanese corporations and add significant value to your company.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Therapeutics
  • Stage:Series A, Series B
  • Geography: Taiwan, United States

Investor stats

  • Total investments: 3
  • Round size: Series A $13M–$23M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
  • APRINOIA Therapeutics — APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies.Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Its goal is to create novel products to meet critical patient needs,including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
  • Sapience Therapeutics — Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme(GBM), which is the most severe and deadly form of brain cancer.The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.
Show all investments...

CDIB Capital
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Taiwan Biotech startups

CCIC CDIB International Corp.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: China, Taiwan, United States

Investor stats

  • Total investments: 45
  • Round size: Series A $1.5M–$16M; Series B $10M–$100M; Series C $4.3M–$40M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $405M in 2015

Portfolio highlights

  • Redcliff — Redcliff is a drone management company that organizes aerial shows and events for private and public organizations.
  • QT Medical — QT Medical’s technology empowers the patients to take an active role in managing their heart disease. Heart disease is responsible for 1 out of every 4 deaths in the U.S. and is the number 1 killer world-wide. No longer do patients with heart disease have to make long trips to their cardiologists, hospitals, or emergency rooms to get diagnostic,hospital-grade ECG scans. They can now perform these tests from the comfort of their homes or anywhere with an internet connection, allowing peace of mind, saving time, reducing stress, and improving outcomes.
  • Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.
Show all investments...

DCI Partners
VC Fund · Tokyo, Tokyo, Japan · 1 investments in Taiwan Biotech startups

DCI Partners is a venture capital firm specializing in the fields of drug discovery and regenerative medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Product Research
  • Stage:Series B, Series A
  • Geography: Japan, Taiwan, United States

Investor stats

  • Total investments: 17
  • Round size: Series A $21M–$105M; Series B $7.1M–$553M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Luxna Biotech — Luxana Biotech is established to contribute to medical treatment for suffering patients, .
  • Scohia Pharma — Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.
  • Surv Biopharma — Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.
Show all investments...

Mega International Commercial Bank
VC Fund · Taipei, T'ai-pei, Taiwan · 1 investments in Taiwan Biotech startups

Mega International Commercial Bank is a result of the merger of International Commercial Bank of China and Chiao Tung Bank.

Show more...

Investment focus

  • Industry: Banking, Payments, Biotechnology
  • Stage:Series A, Debt Financing
  • Geography: Taiwan, Philippines

Investor stats

  • Total investments: 3
  • Round size: Debt Financing $158M–$500M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • China Bank — At China Bank, we are committed to making your success our business. We offer a complete range of deposit, investment, financing, remittance, and insurance products and services, accessible through our vast network of branches nationwide and secure and reliable electronic banking channels: China Bank TellerCard (ATM), China Bank Online (internet& mobile banking) and China Bank Tellerphone (phone banking)
  • Sierra Gorda SCM — Sierra Gorda SCM is a low-grade mining company that focuses on producing copper and molybdenum concentrates.
  • Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Pangu Venture Capital
VC Fund · Beijing, Beijing, China · 1 investments in Taiwan Biotech startups

Pangu Venture Capital a venture capital firm specializing in the Internet, life sciences, cleantech, artificial intelligence, and culture

Show more...

Investment focus

  • Industry: Biotechnology, Apps, SaaS
  • Stage:Series A, Seed, Angel
  • Geography: China, Taiwan, United States

Investor stats

  • Total investments: 6
  • Round size: Series A $12M–$27M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • AutoBrain — AutoBrain focuses on the research and development of advanced and intelligent automatic driving systems.
  • No. 1 workplace — No.1 workplace is a workplace service platform. It helps companies and candidates to achieve job matching through AI technology.
  • Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
Show all investments...

Lippo Group
VC Fund · Tangerang, Jawa Barat, Indonesia · 1 investments in Taiwan Biotech startups

PT Lippo Karawaci Tbk ("Lippo Karawaci") was founded on a vision to impact lives through the development of well-planned sustainable independent townships within green environments and first class physical and social infrastructure. Over more than a decade, the Company has proven itself to be a highly trusted property developer with amost recognisable brand name. It is the owner of the largest diversified landbank and a leader in pioneering projects in strategic locations throughout Indonesia. Through a merger of 8 property related companies in 2004 the Company has expanded its business portfolio to encompass urban development, large scale integrated developments, retail malls, healthcare, hotels and leisure, as well as a fee-based income portfolio.Lippo Karawaci is now the largest listed property company in Indonesia by market capitalisation, assets and revenue, with a unique and integrated business model. It operates Indonesia’s premier private hospital group, the only one achieving world class standards, and is an undisputed retail property industry leader.

Show more...

Investment focus

  • Industry: Internet, E-Commerce, FinTech
  • Stage:Seed, Series A
  • Geography: United States, Singapore, China

Investor stats

  • Total investments: 9
  • Round size: Seed $3.5M–$4.8M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • Tencent — Tencent is an internet service portal offering value-added internet, mobile, telecom, and online advertising services. Its communications and social platforms Weixin and QQ connect users with each other, with digital content and daily life services in just a few clicks. Tencent has maintained steady growth under its user-oriented operatingstrategies. It provides value-added internet, mobile, and telecom services, as well as online advertising under the strategic goal of providing users with "one-stop online lifestyle services." Tencent’s Internet platforms in China – QQ (QQ Instant Messenger), WeChat, QQ.com, QQ Games, Qzone, 3g.QQ.com, SoSo, PaiPai, and Tenpay – aim to address the various needs of internet users, including communication, information, entertainment, e-commerce, and others.In September 2013, Tencent's market valuation rose to $101 billion, and as of November 21, 2013, QQ had 2 billion active users and WeChat had 650 million monthly active users. The numbers of active users for QQ mail, Qzone, Tencent Weibo, and QQ news were 274 million, 626 million, 220 million, and 150 million, respectively.Tencent was founded in November of 1998. In April 2000, the IDG and PCCW invested a total of $2.2 million dollars in the company. Tencent was listed on the Hong Kong Stock Exchange (SEHK) on June 16, 2004. Baidu, Alibaba, and Netease are Tencent's major competitors.
  • Fairbanc — Fairbanc is a scalable, AI-powered mobile loan and payments platform for emerging market small-medium enterprises (SMEs) that requires no collateral or credit history.The company's AI-powered platform can read digital footprints such as transaction history with large suppliers, and data on the mobile phone to grant instant digital creditline that SMEs can use to purchase inventories from our selected suppliers. Fairbanc's proven gender-intelligent ecosystem for loans and payments can be used in many vertical markets, eliminating the shortcomings of cash. Retail shop-owners can boost sales up to 20%, eliminate cash shortages, enjoy an easier payments regimen, and develop a credit history; suppliers receive more consistent order cycles, more instant payments upon delivery, and SKU sales expansion.
  • MoolahGo — The leading MAS-licensed payment platform purpose-built for Asian businesses. Pay, collect and manage in 40+ currencies including every major ASEAN market.
Show all investments...

Taiwan Surface Mounting Technology
VC Fund · Taoyüan, T'ai-wan, Taiwan · 1 investments in Taiwan Biotech startups

Taiwan Surface Mounting Technology assembles printed circuit boards.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Taiwan

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
Show all investments...

Might Electronic
VC Fund · Hsinchu, T'ai-wan, Taiwan · 1 investments in Taiwan Biotech startups

Matt Electronics provides one-stop services from product development, design verification, small-scale trial production, mass production to international logistics.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Taiwan

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
Show all investments...

Integrated Capital
VC Fund · Wan Chai, Hong Kong Island, Hong Kong · 1 investments in Taiwan Biotech startups

Integrated Capital is a multi strategy investment firm investing across private and public equity, private credit and special situations.

Show more...

Investment focus

  • Industry: E-Commerce, Food and Beverage, Automotive
  • Stage:Series A, Seed, Series B
  • Geography: India, Taiwan, Croatia

Investor stats

  • Total investments: 13
  • Round size: Seed $6.5M–$6.5M; Series A $3.4M–$28M; Series B $12M–$40M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Entri — India's leading vernacular learning platform for Job Seekers. Learn Coding, Digital Marketing, Commerce, Spoken English and more.
  • The Naked Market — The Naked Market
  • Surglasses — Surglasses specializes in providing cutting-edge augmented reality surgery systems, specifically designed for orthopedics and neurosurgery. These systems offer precise surgical assistance and enhance surgical success rates, improving medical quality and patient safety.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Taiwan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Taiwan Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists